CN Stock MarketDetailed Quotes

300482 Guangzhou Wondfo Biotech

Watchlist
  • 27.65
  • -0.06-0.22%
Market Closed May 29 15:00 CST
13.04BMarket Cap25.96P/E (TTM)

Guangzhou Wondfo Biotech Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
56.27%1.17B
-27.72%840.3M
226.30%732.82M
79.15%1.04B
27.88%749M
16.70%1.16B
-75.46%224.58M
-39.37%582.19M
-37.95%585.7M
-29.27%996.15M
Transactional financial assets
-21.28%1.01B
-22.99%722.45M
-9.30%1.35B
-19.33%1.06B
150.56%1.28B
63.79%938.07M
269.66%1.49B
109.12%1.32B
36.54%512.32M
458.23%572.73M
Notes receivable and accounts receivable
31.36%744.11M
10.89%599.87M
-10.82%568.8M
-7.21%588.51M
-72.47%566.47M
7.81%540.97M
18.74%637.79M
22.11%634.26M
417.21%2.06B
85.90%501.78M
-Notes receivable
-90.32%195.22K
104.93%1.65M
-65.86%1.52M
-64.59%2.91M
48.38%2.02M
-76.71%806.42K
-5.69%4.44M
37.67%8.21M
79.14%1.36M
468.75%3.46M
-Accounts receivable
31.79%743.92M
10.75%598.22M
-10.43%567.28M
-6.46%585.6M
-72.55%564.45M
8.40%540.16M
18.96%633.35M
21.93%626.05M
417.86%2.06B
85.03%498.32M
Other receivables (including interest and dividends)
-31.77%58.76M
-22.35%51.72M
-30.45%75.28M
-1.46%78.62M
3.85%86.12M
2.95%66.6M
-1.57%108.23M
-24.98%79.79M
18.74%82.93M
-5.38%64.7M
-Other receivable
----
----
----
-1.46%78.62M
----
2.95%66.6M
----
-24.98%79.79M
----
-5.38%64.7M
Contractual assets
----
----
----
----
----
----
--0
----
----
----
Advance payment
-33.97%26.11M
-35.01%17.26M
-45.89%27.87M
-55.64%32.54M
-68.92%39.55M
-50.40%26.56M
-13.65%51.5M
1.99%73.37M
153.22%127.22M
52.23%53.54M
Inventories
-25.67%346.89M
-12.14%351.4M
-33.58%381.74M
-33.44%415.73M
-38.46%466.71M
3.55%399.97M
23.04%574.7M
25.44%624.62M
74.24%758.37M
2.54%386.24M
Receivable financing
----
----
----
----
----
----
--0
----
----
----
Assets held for sale
----
----
----
----
----
----
--0
----
----
----
Non-current assets due within one year
----
----
----
----
----
--200.26M
--0
----
----
----
Other current assets
2,868.37%693.45M
4,110.41%650.34M
81.39%18.85M
266.22%25.95M
277.53%23.36M
49.12%15.45M
-0.34%10.39M
-17.16%7.08M
-94.15%6.19M
12.10%10.36M
Total current assets
25.99%4.05B
-3.49%3.23B
1.93%3.16B
-2.17%3.25B
-22.17%3.21B
29.58%3.35B
23.74%3.1B
18.79%3.32B
73.69%4.13B
13.88%2.59B
Non Current assets
Debt investment
-47.76%215.91M
-70.31%213.94M
-76.81%211.87M
-76.85%209.83M
-0.07%413.34M
75.01%720.48M
123.00%913.6M
122.35%906.51M
-26.02%413.63M
-25.93%411.68M
Other debt investment
----
----
----
----
----
----
--0
----
----
----
Other equity investment
-55.54%89.18M
-55.46%89.18M
-10.16%203.07M
-9.94%203.57M
-11.27%200.57M
-11.42%200.22M
20.42%226.04M
20.42%226.04M
20.42%226.04M
20.42%226.04M
Other non-current financial assets
----
----
----
----
----
----
--0
----
----
----
Investment real estate
----
----
----
----
----
----
--0
----
----
----
Long-term equity investment
25.05%453.62M
11.79%406.36M
12.65%391.34M
15.90%392.88M
9.08%362.74M
8.94%363.52M
2.24%347.39M
13.82%338.98M
18.00%332.54M
18.39%333.7M
Long term receivable account
----
----
----
----
----
----
--0
----
----
----
Fixed assets
----
----
----
1.87%977.33M
----
13.16%963.8M
----
72.84%959.38M
----
63.66%851.74M
Constru in process
----
----
----
221.59%296.76M
----
1,116.01%199.14M
----
-52.31%92.28M
----
-89.51%16.38M
Productive biological assets
----
----
----
----
----
----
--0
----
----
----
Oil and gas assets
----
----
----
----
----
----
--0
----
----
----
Intangible assets
-6.43%188.32M
-4.51%194.52M
-15.99%190.87M
-15.59%197.96M
-20.21%201.26M
-2.11%203.71M
26.24%227.21M
28.99%234.52M
44.75%252.25M
15.49%208.11M
Development expenditure
31.37%65.65M
28.94%66.74M
25.31%69.75M
-2.32%53.55M
-8.53%49.98M
-4.31%51.76M
-35.69%55.66M
-14.75%54.83M
-4.67%54.64M
23.64%54.09M
Goodwill
-3.43%111.42M
-3.43%111.42M
-27.23%115.37M
-27.23%115.37M
-5.21%115.37M
171.38%115.37M
227.66%158.54M
227.66%158.54M
151.53%121.71M
-12.14%42.51M
Long deferred expense
51.81%18.23M
0.12%13.29M
-20.76%12.44M
-14.22%13.32M
-38.38%12.01M
-15.23%13.28M
-0.93%15.7M
7.90%15.53M
33.42%19.48M
-0.42%15.66M
Deferred tax assets
4.06%59.93M
6.71%57.47M
-0.84%50.48M
-5.84%49.77M
-5.40%57.59M
25.93%53.86M
19.85%50.91M
102.55%52.85M
100.76%60.88M
74.95%42.77M
Usufruct assets
177.98%56.05M
70.64%45.01M
124.07%49.91M
125.30%55.68M
-31.51%20.16M
-30.54%26.38M
146.57%22.27M
235.46%24.71M
209.54%29.44M
37.71%37.97M
Other non current assets
-34.29%18.95M
-16.69%32.83M
-5.12%28.64M
-1.44%30.3M
-68.06%28.84M
32.84%39.41M
-29.97%30.19M
-32.10%30.74M
286.65%90.27M
39.05%29.66M
Total non current assets
-2.93%2.62B
-13.98%2.54B
-17.78%2.61B
-16.11%2.6B
7.50%2.7B
29.98%2.95B
45.71%3.18B
52.50%3.09B
20.77%2.51B
10.03%2.27B
Total assets
12.78%6.67B
-8.40%5.77B
-8.05%5.77B
-8.89%5.85B
-10.94%5.92B
29.77%6.3B
33.97%6.27B
32.97%6.42B
48.99%6.64B
12.05%4.86B
Liabilities
Current liabilities
Short term loan
----
----
----
----
-98.64%3M
1,094.70%204.36M
1,142.05%219.79M
1,374.35%221.05M
2,116.81%220.13M
-79.88%17.11M
Transactional financial liabilities
----
-33.27%10.44M
--4.65M
--15.64M
--15.64M
--15.64M
----
----
----
----
Notes payable and accounts payable
-16.87%179.04M
-59.24%130.46M
-56.16%132.81M
-50.84%166.12M
-65.03%215.38M
-19.98%320.08M
-11.66%302.94M
-8.44%337.93M
66.22%615.94M
33.55%399.99M
-Notes payable
----
----
----
----
----
----
--0
----
----
----
-Accounts payable
-16.87%179.04M
-59.24%130.46M
-56.16%132.81M
-50.84%166.12M
-65.03%215.38M
-19.98%320.08M
-11.66%302.94M
-8.44%337.93M
66.22%615.94M
33.55%399.99M
Contract liabilities
-10.14%66.9M
-69.16%72.88M
-32.06%64.13M
-41.78%62.19M
-65.16%74.45M
193.38%236.31M
-21.37%94.38M
-45.98%106.81M
106.26%213.71M
-17.54%80.55M
Advance receipts
----
----
----
----
----
----
--0
----
----
----
Salaries payable
18.18%86.71M
-8.33%151.05M
-67.09%42.99M
-52.38%96.51M
-44.25%73.37M
20.76%164.77M
160.93%130.64M
129.25%202.65M
71.60%131.6M
-2.42%136.45M
Taxs payable
-23.17%52.55M
-56.80%37.37M
-71.91%34.26M
-75.07%40.29M
-60.21%68.39M
228.07%86.5M
237.39%121.98M
120.41%161.64M
176.95%171.89M
-61.49%26.37M
Other payable (including interest and dividends)
-15.21%48.77M
-29.99%61.58M
-55.58%46.88M
-63.33%54.29M
-76.42%57.52M
0.22%87.95M
4.34%105.52M
38.52%148.03M
141.79%243.94M
-3.23%87.76M
-Other payable
----
----
----
-63.33%54.29M
----
0.22%87.95M
----
38.52%148.03M
----
-3.23%87.76M
Hold and for sell liabilities
----
----
----
----
----
----
--0
----
----
----
Non current liabilities due within one year
96.51%20.78M
12.73%19.01M
21.76%21.6M
-24.63%22.64M
-66.25%10.57M
-58.63%16.86M
21.34%17.74M
253.14%30.04M
277.87%31.33M
98.04%40.76M
Other current liabilities
-43.47%769.25K
-82.63%1.45M
-8.24%549.94K
-44.34%547.03K
153.88%1.36M
224.80%8.33M
--599.32K
524.54%982.83K
119.08%536.01K
-19.41%2.56M
Total current liabilities
-12.35%455.51M
-57.56%484.23M
-64.99%347.88M
-62.10%458.23M
-68.10%519.67M
44.16%1.14B
45.55%993.6M
40.75%1.21B
122.47%1.63B
-1.67%791.54M
Current liabilities
Long term loan
----
----
----
----
----
----
--0
----
----
----
Bonds payable
3.82%559.6M
3.82%552.84M
3.81%546.09M
4.34%545.5M
4.40%539.03M
4.27%532.49M
4.30%526.04M
4.56%522.8M
4.22%516.31M
4.35%510.69M
Long term salaries pay
----
----
----
----
----
----
--0
----
----
----
Estimate liabilities
----
----
----
----
----
----
--0
----
----
----
Deferred tax liabilities
-1.09%53.88M
-1.13%55.12M
17.31%57.67M
14.90%56.16M
87.05%54.47M
87.73%55.75M
130.46%49.16M
227.74%48.88M
141.30%29.12M
226.42%29.7M
Long term deferred income
-7.49%43.35M
61.12%37.21M
55.06%40.93M
12.09%41.52M
10.98%46.86M
145.70%23.1M
111.95%26.4M
188.47%37.05M
15.14%42.22M
15.96%9.4M
Lease liabilities
229.58%37.14M
147.53%27.69M
428.76%30.04M
799.35%34.51M
19.33%11.27M
7.30%11.19M
-37.11%5.68M
-47.91%3.84M
-0.70%9.44M
-35.10%10.42M
Other non current liabilities
----
----
----
----
----
----
--0
----
----
----
Total non current liabilities
6.50%693.97M
8.09%672.87M
11.11%674.73M
10.63%677.7M
9.13%651.62M
11.12%622.53M
10.99%607.27M
12.74%612.56M
5.81%597.1M
4.70%560.21M
Total liabilities
-1.86%1.15B
-34.39%1.16B
-36.12%1.02B
-37.64%1.14B
-47.39%1.17B
30.47%1.76B
30.17%1.6B
29.90%1.82B
71.70%2.23B
0.87%1.35B
Shareholders equity
Paid-in capital
6.18%471.97M
0.00%444.52M
0.00%444.52M
-0.07%444.51M
-0.07%444.51M
-0.10%444.51M
-0.10%444.51M
-0.03%444.83M
29.85%444.83M
29.89%444.95M
Other equity instruments
-0.01%107.49M
-0.01%107.49M
-0.02%107.49M
-0.01%107.5M
-0.07%107.5M
-0.10%107.5M
0.01%107.51M
-0.00%107.51M
-0.26%107.57M
-0.24%107.61M
Capital reserve funds
82.53%1.43B
-1.29%765.52M
-4.82%770.78M
-4.47%770.75M
-1.66%781.82M
-1.46%775.53M
0.61%809.77M
2.92%806.79M
-7.93%795M
-9.12%787.01M
Surplus reserve funds
0.00%261.06M
0.00%261.06M
0.00%261.06M
0.00%261.06M
0.00%261.06M
0.00%261.06M
29.68%261.06M
29.68%261.06M
29.68%261.06M
29.68%261.06M
Retained profit
9.06%3.39B
9.18%3.17B
4.63%3.08B
4.62%3.02B
13.29%3.11B
57.85%2.9B
55.74%2.95B
58.45%2.89B
72.40%2.74B
28.14%1.84B
Less:Treasury stock
-15.79%132.46M
-15.79%132.46M
13.75%144.04M
-15.73%113.95M
15.54%157.3M
12.96%157.3M
-17.66%126.63M
28.64%135.21M
25.78%136.14M
9.17%139.25M
Other composite income
-1,320.94%-101.18M
-1,386.69%-101.59M
-83.81%10.11M
-82.51%9.81M
-84.52%8.29M
-84.69%7.9M
299.11%62.46M
262.73%56.09M
221.39%53.54M
219.94%51.57M
Ordinary risk reserve funds
----
----
----
----
----
----
--0
----
----
----
Specific reserves
----
----
----
----
----
----
--0
----
----
----
Shareholders equity without minority interests
19.09%5.42B
3.96%4.52B
0.62%4.53B
1.62%4.5B
6.67%4.55B
29.55%4.34B
36.01%4.51B
35.41%4.43B
41.61%4.27B
17.97%3.35B
Minority interests
-47.61%100.77M
-49.09%98.66M
27.64%210.78M
25.87%210.98M
28.93%192.34M
28.37%193.8M
18.91%165.14M
9.16%167.62M
0.56%149.17M
-0.23%150.97M
Total shareholder equity
16.39%5.52B
1.69%4.61B
1.57%4.74B
2.51%4.71B
7.42%4.75B
29.50%4.54B
35.32%4.67B
34.23%4.59B
39.68%4.42B
17.05%3.5B
Total liabilityies and equity
12.78%6.67B
-8.40%5.77B
-8.05%5.77B
-8.89%5.85B
-10.94%5.92B
29.77%6.3B
33.97%6.27B
32.97%6.42B
48.99%6.64B
12.05%4.86B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds 56.27%1.17B-27.72%840.3M226.30%732.82M79.15%1.04B27.88%749M16.70%1.16B-75.46%224.58M-39.37%582.19M-37.95%585.7M-29.27%996.15M
Transactional financial assets -21.28%1.01B-22.99%722.45M-9.30%1.35B-19.33%1.06B150.56%1.28B63.79%938.07M269.66%1.49B109.12%1.32B36.54%512.32M458.23%572.73M
Notes receivable and accounts receivable 31.36%744.11M10.89%599.87M-10.82%568.8M-7.21%588.51M-72.47%566.47M7.81%540.97M18.74%637.79M22.11%634.26M417.21%2.06B85.90%501.78M
-Notes receivable -90.32%195.22K104.93%1.65M-65.86%1.52M-64.59%2.91M48.38%2.02M-76.71%806.42K-5.69%4.44M37.67%8.21M79.14%1.36M468.75%3.46M
-Accounts receivable 31.79%743.92M10.75%598.22M-10.43%567.28M-6.46%585.6M-72.55%564.45M8.40%540.16M18.96%633.35M21.93%626.05M417.86%2.06B85.03%498.32M
Other receivables (including interest and dividends) -31.77%58.76M-22.35%51.72M-30.45%75.28M-1.46%78.62M3.85%86.12M2.95%66.6M-1.57%108.23M-24.98%79.79M18.74%82.93M-5.38%64.7M
-Other receivable -------------1.46%78.62M----2.95%66.6M-----24.98%79.79M-----5.38%64.7M
Contractual assets --------------------------0------------
Advance payment -33.97%26.11M-35.01%17.26M-45.89%27.87M-55.64%32.54M-68.92%39.55M-50.40%26.56M-13.65%51.5M1.99%73.37M153.22%127.22M52.23%53.54M
Inventories -25.67%346.89M-12.14%351.4M-33.58%381.74M-33.44%415.73M-38.46%466.71M3.55%399.97M23.04%574.7M25.44%624.62M74.24%758.37M2.54%386.24M
Receivable financing --------------------------0------------
Assets held for sale --------------------------0------------
Non-current assets due within one year ----------------------200.26M--0------------
Other current assets 2,868.37%693.45M4,110.41%650.34M81.39%18.85M266.22%25.95M277.53%23.36M49.12%15.45M-0.34%10.39M-17.16%7.08M-94.15%6.19M12.10%10.36M
Total current assets 25.99%4.05B-3.49%3.23B1.93%3.16B-2.17%3.25B-22.17%3.21B29.58%3.35B23.74%3.1B18.79%3.32B73.69%4.13B13.88%2.59B
Non Current assets
Debt investment -47.76%215.91M-70.31%213.94M-76.81%211.87M-76.85%209.83M-0.07%413.34M75.01%720.48M123.00%913.6M122.35%906.51M-26.02%413.63M-25.93%411.68M
Other debt investment --------------------------0------------
Other equity investment -55.54%89.18M-55.46%89.18M-10.16%203.07M-9.94%203.57M-11.27%200.57M-11.42%200.22M20.42%226.04M20.42%226.04M20.42%226.04M20.42%226.04M
Other non-current financial assets --------------------------0------------
Investment real estate --------------------------0------------
Long-term equity investment 25.05%453.62M11.79%406.36M12.65%391.34M15.90%392.88M9.08%362.74M8.94%363.52M2.24%347.39M13.82%338.98M18.00%332.54M18.39%333.7M
Long term receivable account --------------------------0------------
Fixed assets ------------1.87%977.33M----13.16%963.8M----72.84%959.38M----63.66%851.74M
Constru in process ------------221.59%296.76M----1,116.01%199.14M-----52.31%92.28M-----89.51%16.38M
Productive biological assets --------------------------0------------
Oil and gas assets --------------------------0------------
Intangible assets -6.43%188.32M-4.51%194.52M-15.99%190.87M-15.59%197.96M-20.21%201.26M-2.11%203.71M26.24%227.21M28.99%234.52M44.75%252.25M15.49%208.11M
Development expenditure 31.37%65.65M28.94%66.74M25.31%69.75M-2.32%53.55M-8.53%49.98M-4.31%51.76M-35.69%55.66M-14.75%54.83M-4.67%54.64M23.64%54.09M
Goodwill -3.43%111.42M-3.43%111.42M-27.23%115.37M-27.23%115.37M-5.21%115.37M171.38%115.37M227.66%158.54M227.66%158.54M151.53%121.71M-12.14%42.51M
Long deferred expense 51.81%18.23M0.12%13.29M-20.76%12.44M-14.22%13.32M-38.38%12.01M-15.23%13.28M-0.93%15.7M7.90%15.53M33.42%19.48M-0.42%15.66M
Deferred tax assets 4.06%59.93M6.71%57.47M-0.84%50.48M-5.84%49.77M-5.40%57.59M25.93%53.86M19.85%50.91M102.55%52.85M100.76%60.88M74.95%42.77M
Usufruct assets 177.98%56.05M70.64%45.01M124.07%49.91M125.30%55.68M-31.51%20.16M-30.54%26.38M146.57%22.27M235.46%24.71M209.54%29.44M37.71%37.97M
Other non current assets -34.29%18.95M-16.69%32.83M-5.12%28.64M-1.44%30.3M-68.06%28.84M32.84%39.41M-29.97%30.19M-32.10%30.74M286.65%90.27M39.05%29.66M
Total non current assets -2.93%2.62B-13.98%2.54B-17.78%2.61B-16.11%2.6B7.50%2.7B29.98%2.95B45.71%3.18B52.50%3.09B20.77%2.51B10.03%2.27B
Total assets 12.78%6.67B-8.40%5.77B-8.05%5.77B-8.89%5.85B-10.94%5.92B29.77%6.3B33.97%6.27B32.97%6.42B48.99%6.64B12.05%4.86B
Liabilities
Current liabilities
Short term loan -----------------98.64%3M1,094.70%204.36M1,142.05%219.79M1,374.35%221.05M2,116.81%220.13M-79.88%17.11M
Transactional financial liabilities -----33.27%10.44M--4.65M--15.64M--15.64M--15.64M----------------
Notes payable and accounts payable -16.87%179.04M-59.24%130.46M-56.16%132.81M-50.84%166.12M-65.03%215.38M-19.98%320.08M-11.66%302.94M-8.44%337.93M66.22%615.94M33.55%399.99M
-Notes payable --------------------------0------------
-Accounts payable -16.87%179.04M-59.24%130.46M-56.16%132.81M-50.84%166.12M-65.03%215.38M-19.98%320.08M-11.66%302.94M-8.44%337.93M66.22%615.94M33.55%399.99M
Contract liabilities -10.14%66.9M-69.16%72.88M-32.06%64.13M-41.78%62.19M-65.16%74.45M193.38%236.31M-21.37%94.38M-45.98%106.81M106.26%213.71M-17.54%80.55M
Advance receipts --------------------------0------------
Salaries payable 18.18%86.71M-8.33%151.05M-67.09%42.99M-52.38%96.51M-44.25%73.37M20.76%164.77M160.93%130.64M129.25%202.65M71.60%131.6M-2.42%136.45M
Taxs payable -23.17%52.55M-56.80%37.37M-71.91%34.26M-75.07%40.29M-60.21%68.39M228.07%86.5M237.39%121.98M120.41%161.64M176.95%171.89M-61.49%26.37M
Other payable (including interest and dividends) -15.21%48.77M-29.99%61.58M-55.58%46.88M-63.33%54.29M-76.42%57.52M0.22%87.95M4.34%105.52M38.52%148.03M141.79%243.94M-3.23%87.76M
-Other payable -------------63.33%54.29M----0.22%87.95M----38.52%148.03M-----3.23%87.76M
Hold and for sell liabilities --------------------------0------------
Non current liabilities due within one year 96.51%20.78M12.73%19.01M21.76%21.6M-24.63%22.64M-66.25%10.57M-58.63%16.86M21.34%17.74M253.14%30.04M277.87%31.33M98.04%40.76M
Other current liabilities -43.47%769.25K-82.63%1.45M-8.24%549.94K-44.34%547.03K153.88%1.36M224.80%8.33M--599.32K524.54%982.83K119.08%536.01K-19.41%2.56M
Total current liabilities -12.35%455.51M-57.56%484.23M-64.99%347.88M-62.10%458.23M-68.10%519.67M44.16%1.14B45.55%993.6M40.75%1.21B122.47%1.63B-1.67%791.54M
Current liabilities
Long term loan --------------------------0------------
Bonds payable 3.82%559.6M3.82%552.84M3.81%546.09M4.34%545.5M4.40%539.03M4.27%532.49M4.30%526.04M4.56%522.8M4.22%516.31M4.35%510.69M
Long term salaries pay --------------------------0------------
Estimate liabilities --------------------------0------------
Deferred tax liabilities -1.09%53.88M-1.13%55.12M17.31%57.67M14.90%56.16M87.05%54.47M87.73%55.75M130.46%49.16M227.74%48.88M141.30%29.12M226.42%29.7M
Long term deferred income -7.49%43.35M61.12%37.21M55.06%40.93M12.09%41.52M10.98%46.86M145.70%23.1M111.95%26.4M188.47%37.05M15.14%42.22M15.96%9.4M
Lease liabilities 229.58%37.14M147.53%27.69M428.76%30.04M799.35%34.51M19.33%11.27M7.30%11.19M-37.11%5.68M-47.91%3.84M-0.70%9.44M-35.10%10.42M
Other non current liabilities --------------------------0------------
Total non current liabilities 6.50%693.97M8.09%672.87M11.11%674.73M10.63%677.7M9.13%651.62M11.12%622.53M10.99%607.27M12.74%612.56M5.81%597.1M4.70%560.21M
Total liabilities -1.86%1.15B-34.39%1.16B-36.12%1.02B-37.64%1.14B-47.39%1.17B30.47%1.76B30.17%1.6B29.90%1.82B71.70%2.23B0.87%1.35B
Shareholders equity
Paid-in capital 6.18%471.97M0.00%444.52M0.00%444.52M-0.07%444.51M-0.07%444.51M-0.10%444.51M-0.10%444.51M-0.03%444.83M29.85%444.83M29.89%444.95M
Other equity instruments -0.01%107.49M-0.01%107.49M-0.02%107.49M-0.01%107.5M-0.07%107.5M-0.10%107.5M0.01%107.51M-0.00%107.51M-0.26%107.57M-0.24%107.61M
Capital reserve funds 82.53%1.43B-1.29%765.52M-4.82%770.78M-4.47%770.75M-1.66%781.82M-1.46%775.53M0.61%809.77M2.92%806.79M-7.93%795M-9.12%787.01M
Surplus reserve funds 0.00%261.06M0.00%261.06M0.00%261.06M0.00%261.06M0.00%261.06M0.00%261.06M29.68%261.06M29.68%261.06M29.68%261.06M29.68%261.06M
Retained profit 9.06%3.39B9.18%3.17B4.63%3.08B4.62%3.02B13.29%3.11B57.85%2.9B55.74%2.95B58.45%2.89B72.40%2.74B28.14%1.84B
Less:Treasury stock -15.79%132.46M-15.79%132.46M13.75%144.04M-15.73%113.95M15.54%157.3M12.96%157.3M-17.66%126.63M28.64%135.21M25.78%136.14M9.17%139.25M
Other composite income -1,320.94%-101.18M-1,386.69%-101.59M-83.81%10.11M-82.51%9.81M-84.52%8.29M-84.69%7.9M299.11%62.46M262.73%56.09M221.39%53.54M219.94%51.57M
Ordinary risk reserve funds --------------------------0------------
Specific reserves --------------------------0------------
Shareholders equity without minority interests 19.09%5.42B3.96%4.52B0.62%4.53B1.62%4.5B6.67%4.55B29.55%4.34B36.01%4.51B35.41%4.43B41.61%4.27B17.97%3.35B
Minority interests -47.61%100.77M-49.09%98.66M27.64%210.78M25.87%210.98M28.93%192.34M28.37%193.8M18.91%165.14M9.16%167.62M0.56%149.17M-0.23%150.97M
Total shareholder equity 16.39%5.52B1.69%4.61B1.57%4.74B2.51%4.71B7.42%4.75B29.50%4.54B35.32%4.67B34.23%4.59B39.68%4.42B17.05%3.5B
Total liabilityies and equity 12.78%6.67B-8.40%5.77B-8.05%5.77B-8.89%5.85B-10.94%5.92B29.77%6.3B33.97%6.27B32.97%6.42B48.99%6.64B12.05%4.86B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg